Population pharmacokinetics of methotrexate in the guinea pig.
The population pharmacokinetics of an antitumoral and antiinflammatory agent, methotrexate (MTX), a folic acid antagonist, was studied in guinea pigs. Animals received an acute intraperitoneal injection of 0.25, 1 or 5 mg/kg MTX. Blood sampling was carried out for 12 hrs. after MTX administration and plasma drug concentrations were measured by fluorescence polarization immunoassay. The pharmacokinetic (PK) parameters were computed using the bayesian population model. MTX reached the level of detection at 3 hrs. for the animals injected with the lowest dose (0.25 mg/kg), at 3.5 hrs. for those animals which had the intermediate dose (1 mg/kg) and more than 6 hrs. for animals having received the highest dose (5 mg/kg). Each kinetic parameter (half life, total clearance - CLt, volume of distribution at steady state - VDSS, mean residence time - MRT - and area under curve - AUC) didn't show any significant difference between doses. MTX kinetic was linear for the first two doses (0.25 and 1 mg/kg MTX) and non-linear thereafter. MTX presented a one compartment distribution.
Schlatter
J
J
Service Pharmaceutique, Centre Hospitalier de Gonesse, France. jschlatt@club-internet.fr
Di Blasi-Bouvet
S
S
Raynaud
F
F
Cisternino
S
S
D000818:Animals; D019540:Area Under Curve; D001499:Bayes Theorem; D001682:Biological Availability; D004305:Dose-Response Relationship, Drug; D005493:Folic Acid Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006168:Guinea Pigs; D006207:Half-Life; D007274:Injections, Intraperitoneal; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000493:pharmacokinetics*
D005493:Folic Acid Antagonists; D008727:Methotrexate